Printed from acutecaretesting.org
Articles by F. J. FitzGibbon
Showing articles by "F. J. FitzGibbon"
Article
April 2012
C-reactive protein point-of-care testing for respiratory-tract infections in primary care
Differentiating self-limiting from serious lower-respiratory-tract infections (LRTI) based on medical history and physical examination is challenging in primary care. Many family physicians (FPs) empirically prescribe antibiotics to most LRTI patients.
The use of C-reactive protein (CRP) point-of-care testing as an...
Infection/sepsis
Point-of-care testing
PCT
CRP
Article
January 2012
POCT in the ED - relevant clinical and economical advantages
In the ED, 25 % of patients with angina pectoris with suspected AMI are wrongly diagnosed (no cardiac involvement). As a result, the patient risks are increased and resources are wasted.
We investigated the effect of point-of-care testing (POCT) on ED processes, resource needs, patient risks and overall costs.
POCT...
Cardiac markers
Process optimization
Point-of-care testing
Lactate
Creatinine/urea
D-dimer
Troponins
Natriuretic peptide
Article
October 2011
Choosing cut-offs for NT-proBNP
Various guidelines and recommendations are available for the use of natriuretic peptides in the diagnosis of heart failure.
As it is known that old age may lead to higher natriuretic peptide values in the absence of heart failure, it is relevant to decide whether to use age-dependent reference intervals for clinical...
Cardiac markers
Natriuretic peptide
Article
July 2011
Assessment of plasma D-dimer as a diagnostic and prognostic aid for abdominal aortic aneurysm
Abdominal aortic aneurysms (AAAs) are currently identified by incidental imaging or ultrasound screening.
The potential diagnostic and prognostic value of D-dimer for AAA was assessed in this study. 1260 men from a population-based ultrasound screening study were included, of which 299 had small AAAs monitored by...
Coagulation/fibrinolysis
Creatinine/urea
D-dimer
CRP
Article
April 2011
The importance of preoperative evaluation of NT-proBNP
Postoperative cardiovascular event including myocardial infarction or heart failure is a major cause of morbidity after non-cardiac surgery. Preoperative evaluation including estimation of the probability of perioperative cardiac event and application of non-invasive testing or beta-blocker has been developed, but...
Cardiac markers
Creatinine/urea
CRP
Natriuretic peptide
Article
July 2010
Diagnosis of DVT with D-dimer testing and the Wells score
The following is a copy of an article from Evidence-Based Practice, 2007; 10(12):1-2.
Venous thromboembolism refers to a spectrum of disease that includes both pulmonary embolus and deep-venous thrombosis (DVT).
More than 250,000 people in the United States are diagnosed annually with venous thromboembolic disease;...
Coagulation/fibrinolysis
D-dimer
Article
April 2010
Can lean save lives
PURPOSE – The purpose of this paper is to show how over the last 18 months Bolton Hospitals NHS Trust have been exploring whether or not lean methodologies, often known as the Toyota Production System, can indeed be applied to healthcare.
DESIGN/METHODOLOGY/APPROACH – This paper is a viewpoint.
FINDINGS – One’s...
Process optimization
Information management
Article
April 2010
NT-proBNP as a biomarker of cardioembolic stroke
In about 30-40 % of ischemic strokes, even after an extensive clinical investigation, it is not possible to determine any one etiology. It is possible that a fraction of these strokes, named cryptogenic, happen after an episode of paroxystic atrial fibrillation (AF) that was not registered. Strokes due to atrial...
Cardiac markers
Natriuretic peptide
Article
June 2009
D-dimer as a rule-out test for deep venous thrombosis: Gold standards and bias in negative predictive value
Recent studies of D-dimer as a “rule-out” test for deep venous thrombosis (DVT) frequently have used duplex ultrasound rather than venography as the gold standard.
Because duplex ultrasound has limited ability to image the calf veins, there is potential for ultrasound studies to classify patients with calf DVT as...
Coagulation/fibrinolysis
Hemoglobins
D-dimer
Article
April 2009
Perspectives on the impact of point-of-care testing for cardiac markers on healthcare professional working relationships
Applications of point-of-care testing (POCT) for diagnostic biomarker measurement in healthcare have increased significantly in recent years in a wide range of clinical scenarios. These include infectious disease, critical care, cardiology and other areas of emergency medicine.
Traditionally, routine clinical...
Cardiac markers
Point-of-care testing
Troponins
